Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
Acorda Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Acorda Therapeutics reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, four executives at Acorda Therapeutics received on average a compensation package of $641K, a 34% decrease compared to previous year.
Average pay of disclosed executives at Acorda Therapeutics
Ron Cohen, Chief Executive Officer, received $984K in total, which decreased by 40% compared to 2021. 64% of Cohen's compensation, or $625K, was in salary. Cohen also received $350K in non-equity incentive plan and $9.2K in other compensation.
For fiscal year 2022, the median employee pay was $218,380 at Acorda Therapeutics. Therefore, the ratio of Ron Cohen's pay to the median employee pay was 5 to one.
Kerry Clem, Chief Commercial Officer, received a compensation package of $592K, which decreased by 11% compared to previous year. 70% of the compensation package, or $415K, was in salary.
Lauren Sabella, Chief Operating Officer, earned $530K in 2022, a 35% decrease compared to previous year.
Michael Gesser, Chief Finance Officer and Treasurer, received $459K in 2022, which increases by 51% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2023.